Radiation-induced heart disease after Hodgkin's disease and breast cancer treatment: Dental implications

Journal of the American Dental Association

Volumn 134, Issue 12, 2003, Pages 1615-1620

  Friedlander, Arthur H ^a,b,c   Sung, Eric C ^c,d   Child, John S ^e  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SEDATIVE AGENT; VASOCONSTRICTOR AGENT;

BREAST CARCINOMA; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CORONARY ARTERY ATHEROSCLEROSIS; DENTISTRY; DISEASE PREDISPOSITION; ENDOCARDITIS; HEART DISEASE; HEART INFARCTION; HODGKIN DISEASE; HUMAN; RADIATION INJURY; REVIEW; RISK ASSESSMENT; RISK FACTOR; VALVULAR HEART DISEASE;

EID: 0346341008     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2003.0108     Document Type: Article

References (63)

1. Krieger N, Strong EF, Makosky C, Weuve J. Breast cancer, birth cohorts, and Epstein-Barr virus: methodological issues in exploring the "hygiene hypothesis" in relation to breast cancer, Hodgkin's disease, and stomach cancer. Cancer Epidemiol Biomarkers Prev 2003;12(5):405-11.
2. Alberg AJ, Singh S, May JW, Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer. Curr Opin Oncol 2000;12(6):515-20.
3. Sixel KE, Azhar MC, Ung YC. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys 2001;49:199-204.
4. Eriksson F, Gagliardi G, Liedberg A, et al. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol 2000;55:153-62.
5. Mittal S, Berko B, Bavaria J, Herrman HC. Radiation-induced cardiovascular dysfunction. Am J Cardiol 1996;78:114-5.
6. Keefe D. Cardiovascular emergencies in the cancer patient. Semin Oncol 2000;27:244-55.
7. Basavaraju SR, Easterly CE. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 2002;29:2391-403.
8. Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE. Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintography. Eur J Nucl Med 1997;24:286-92.
9. Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995;31:1205-11.
10. Brand MD, Abadi CA, Aurigemma GP, Dauerman HL, Meyer TE. Radiation-associated valvular disease in Hodgkin's disease is associated with characteristic thickening and fibrosis of the aortic-mitral curtain. J Heart Valve Dis 2001;10:681-5.
11. Katz NM, Hall AW, Cerqueira MD. Radiation induced valvulitis with late leaflet rupture. Heart 2001;86:E20.
12. Handa N, McGregor CG, Danielson GK, et al. Coronary artery bypass grafting in patients with previous mediastinal radiation therapy. J Thorac Cardiovasc Surg 1999;177:1136-42.
13. Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 1996;27:766-73.
14. Knight CJ, Sutton GC. Complete heart block and severe tricuspid regurgitation after radiography: case report and review of literature. Chest 1995;108:1748-51.
15. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993;270:1949-55.
16. Conte MR, Orzan F, Figliomeni MC, Mangiardi L, Brusca A. Bacterial endocarditis of the pulmonary valve damaged by thoracic radiotherapy (in Hodgkin's disease) [in Italian]. G Ital Cardiol 1991;21:1011-5.
17. Lipshultz SE, Sallan SE. Cardiovascular abnormalities in long-term survivors of childhood malignancy. J Clin Oncol 1993;11:1199-203.
18. Jahangiri M, Edmondson SJ, Rees GM. Surgery for radiation-induced valvular disease. J Heart Valve Dis 1995;4:288-90.
19. Toyofuku M, Okimoto T, Tadehara F, et al. Cardiac disease late after chest radiotherapy for Hodgkin's disease: a case report. Jpn Circ J 1999;63:803-5.
20. Kleikamp G, Schnepper U, Korfer R. Coronary artery and aortic valve disease as a long-term sequel of mediastinal and thoracic irradiation. Thorac Cardiovasc Surg 1997;45:27-31.
21. Lund MB, Ihlen H, Voss BM, et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 1996;75:591-5.
22. Thomson AB, Wallace WH. Treatment of paediatric Hodgkin's disease: a balance of risks. Eur J Cancer 2002;38:468-77.
23. Handa N, McGregor CG, Danielson GK, et al. Valvular heart operations in patients with previous mediastinal radiation therapy. Ann Thorac Surg 2001;71:1880-4.
24. Shapiro CL, Recht A. Late effects of adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 1994;16:101-12.
25. Raviprasad GS, Salem BI, Gowda S, Leidenfrost R. Radiation-induced mitral and tricuspid regurgitation with severe ostial coronary artery disease: a case report with successful surgical treatment. Cathet Cardiovasc Diagn 1995;35:146-8.
26. Chenu PC, Schroeder E, Buche M, Marchandise B. Bilateral coronary ostial stenosis and aortic valvular disease after radiotherapy. Eur Heart J 1994;15:1150-1.
27. Horimoto M, Igarashi K, Takenaka T, Batra S. Pulmonary infundibular stenosis, coronary artery disease, and aortic regurgitation caused by mediastinal radiation. Am Heart J 1993;126:1002-5.
28. Suzuki M, Hamada M, Matsumoto Y, Hiwada K, Osuka Y. Aortic valvular disease and right coronary artery stenosis induced by mediastinal irradiation: report of a case. Jpn Circ J 1993;57:467-71.
29. Gansera B, Haschemi A, Angelis I, et al. Cardiac surgery in patients with previous carcinoma of the breast and mediastinal irradiation: is the internal thoracic artery graft obsolete? Thorac Cardiovasc Surg 1999, 47:376-80.
30. Orzan F, Brusca A. Radiation-induced constrictive pericarditis: associated cardiac lesions, therapy and follow-up [in Italian]. G Ital Cardiol 1994;24:817-23.
31. Gyenes G, Rutqvist LE, Liedberg A, Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre-and postoperative irradiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 1998;48:185-90.
32. Gonzaga AT, Antunes MJ. Post-radiation valvular and coronary artery disease. J Heart Valve Dis 1997;6:219-21.
33. Zinzani PL, Gherlinzoni F, Piovaccari G, et al. Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients. Haematologica 1996;81:132-7.
34. Kahn MH, Ettinger SM. Post mediastinal radiation coronary artery disease and its effects on arterial conduits. Catheter Cardiovasc Interv 2001;52:242-8.
35. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-15.
36. Hudson MM, Poquette CA, Lee J, et al. Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol 1998;16:3592-600.
37. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, van Putten WL, Levendag PC. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 1999;51:35-42.
38. Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1998;46:51-62.
39. Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-53.
40. Landau D, Adams EJ, Webb S, Ross G. Cardiac avoidance in breast radiotherapy: a comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol 2001;60:247-55.
41. Gagliardi G, Lax I, Rutqvist LE. Partial irradiation of the heart. Semin Radiat Oncol 2001;11:224-33.
42. Pierce LJ, Butler JB, Martel MK, et al. Postmastectomy radio-therapy of the chest wall: dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 2002;52:1220-30.
43. Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 1998;16:2625-31.
44. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999;43:755-62.
45. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:1757-70.
46. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. N Engl J Med 1995;333:1444-55.
47. Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist LE. Evaluation of irradiated heart volumes in stage 1 breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 1997;15:1348-53.
48. Gyenes G. Radiation-induced ischemic heart disease in breast cancer: a review. Acta Oncol 1998;37:241-6.
49. Buchholz TA. Internal mammary lymph nodes: to treat or not to treat. Int J Radiat Oncol Biol Phys 2000;46:801-3.
50. Freedman GM, Fowble BL, Nicolaou N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 2000;46:805-14.
51. Zambetti M, Moliterni A, Materazzo C, et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J Clin Oncol 2001;19:37-43.
52. Meinardi MT, van Veldhuisen DJ, Gietema JA, et al. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol 2001;19:2746-53.
53. Muren LP, Maurstad G, Hafslund R, Anker G, Dahl O. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol 2002;62:173-83.
54. Kuske R. Adjuvant chest wall and nodal irradiation: maximize cure, minimize late cardiac toxicity. J Clin Oncol 1998;16:2579-82.
55. Gagliardi G, Lax I, Söderström S, Gyenes G, Rutqvist LE. Prediction of excess long-term cardiac mortality after radiotherapy of stage 1 breast cancer. Radiother Oncol 1998;46:63-71.
56. Randall CW, Kressin NR, Garcia RI, Sims H, Kazis L, Jones JA. Heart murmurs: are older male dental patients aware of their existence? JADA 2001;132:171-6.
57. Sirois DA, Fatahzadeh M. Valvular heart disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:15-9.
58. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JADA 1997;128:1142-51.
59. Scully C, Roberts G, Shotts R. The mouth in heart disease. Practitioner 2001;245:432-7.
60. Carmona IT, Diz Dios P, Scully C. An update on the controversies in bacterial endocarditis of oral origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:660-70.
61. Pallasch TJ, Gage TW, Taubert KA. The 1997 prevention of bacterial endocarditis recommendations by the American Heart Association: questions and answers. J Calif Dent Assoc 1999;27:393-9.
62. Mask AG Jr. Medical management of the patient with cardiovascular disease. Periodontol 2000;23:136-41.
63. Yagiela JA. Injectable and topical local anesthetics. In: Ciancio SG, ed. ADA guide to dental therapeutics. 2nd ed. Chicago: American Dental Association; 2000:1-16.